Skip to main content
SpringerLink
Log in

Idenex Pharmaceuticals, Inc. have had a clinical hold placed by the US FDA on IDX-19368,

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Idenix Pharmaceuticals Inc.Idenix Provides Update on IDX19368 Development Program Media Release: 27 Aug 2012. Available from: URL: http://www.idenix.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Idenex Pharmaceuticals, Inc. have had a clinical hold placed by the US FDA on IDX-19368,. React. Wkly. 1418, 3 (2012). https://doi.org/10.2165/00128415-201214180-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214180-00009

Keywords

Search

Navigation